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and knee pain (r=0.598, p=0.01), stiffness (r=0.525, p=0.025)
and function (r=0.689, p=0.002) as determined by regression
analyses and presented in Figures 1, 2 and 3, respectively.
Figure 1. Pain Score vs serum CS846.
Figure 2. Stiffness Score vs serum CS846.
Figure 3. Function Score vs serum CS846.
All of these results suggest that those with a higher attempt at
abnormal cartilage synthesis have more severe symptoms than
those with lower levels abnormal cartilage repari. COMP levels
reﬂecting the amount of cartilage degeneration did not appear to
correlate with any WOMAC symptoms.
Conclusions: Knee pain, stiffness and physical function appear
to be related to serum CS846 levels suggesting that symptoms
are worse in those patients with greater abnormal cartilage
synthesis. These results may suggest that CS846 is a sensitive
clinical outcome and may be useful in trials of knee OA. There
was no signiﬁcant relationship between knee symptoms and
serum COMP level and this may partially be expained by the
fact that there was a rather large variation in COMP levels in this
population (mean 9.85 µg/L, SD=8.27 µg/L). In addition, these
serum levels were acquired at only one time point while symptom
outcomes reﬂected pain, stiffness and function over a 48 hour
period.
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Purpose: Adiponectin and resistin, adipocyte-derived peptides,
have been previously shown to be implicated in the pathogenesis
of obesity-related diseases. Obesity is suggested as one of the
risk factors for the development of osteoarthritis (OA) at various
sites in middle aged women. The aim of this study was to
compare serum adiponectin and resistin levels between female
patients with erosive osteoarthritis (EOA) and non-erosive OA of
the hands.
Methods: Seventy-four female patients with OA of the hands
according to ACR criteria were enrolled into this study. The ﬁrst
study group consisted of patients with EOA (n=48) and second
of non-erosive OA of the hands (n=26). Adiponectin and resistin
concentrations were analyzed by ELISA assays. Systemic in-
ﬂammation was measured by high-sensitivity C-reactive protein
(hs-CRP).
Results: Both groups were similar in terms of age and body
mass index (BMI). None of the adipocytokines correlated with
age or BMI. Mean CRP did not differ between patients with EOA
and non-erosive OA of the hands (1.78±1.22 vs. 1.87±1.61
mg/l, p=0.82). The level of serum adiponectin was signiﬁcantly
higher in erosive than in non-erosive group (28.7±13.14 vs.
21.25±11.40 µg/ml, p=0.03). On the other hand resistin levels
did not show any difference between those groups (4.59±1.88
vs. 5.48±2.72 ng/ml, p=0.1). Moreover, serum resistin, but not
adiponectin, correlated with CRP (p<0.02) only in the patients
with EOA.
Conclusions: Increased circulating adiponectin in patients with
EOA compared to non-erosive OA of the hands may be re-
lated to the pathogenesis of joint erosions in patients with OA.
Further studies are necessary to clarify the functional role of
adipocytokines in the pathogenesis of OA.
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Purpose: The purpose of this study was to compare the inter-
and intra-assay reproducibility of cytokine measurements be-
tween two multiplex ELISA technologies, Searchlight (SL, from
Pierce/Endogen) and Luminex (LX, from BioSource/Invitrogen)
in order to validate a method for future studies.
Methods: Fifteen analytes were identiﬁed as potential candi-
dates of interest in various future studies. Nine analytes (BDNF,
GCSF, IL-1ra, IL-2, IL-6, IL-8, IL-10, and VEGF) were avail-
able for both SL and LX. Two additional analytes (Leptin and
